Enquiry Now
Loading...
| A03771 | Pages: NA | Aug 2021 | 3173 Views | | |
| Author(s) : NA | Tables: NA | Charts: NA |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Cerebral Thrombectomy Systems Market
Request Now !Thrombectomy is a surgical procedure of removing thrombi (blood clots) from a blood vessel. The removal of a blood clot from brain is known as cerebral thrombectomy. Cerebral thrombectomy systems help remove blood clots from the brain. The blockage is caused due to an embolus, an atheromatous stenosis or a thrombus of one or more arteries.
Growth in incidences of chronic inflammatory diseases, sickle cell anemia, and kidney problems drive the market. However, high cost associated with the surgical procedures and less awareness among individuals impede the market growth. Moreover, R&D investments coupled with technological advancements in healthcare sector create lucrative opportunities for key market players in developing cost-efficient products.
The global cerebral thrombectomy systems market is segmented based on product type, utility, and geography. Based on product type, the market is divided into suction devices, catheters with balloons, snares, enveloping coil, rheolytic devices, and laser-based devices. Based on utility, it is bifurcated into reusable devices and disposable devices. Based on geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Comprehensive competitive analysis and profiles of major market players, such as Terumo Corporation, Johnson and Johnson, Inc., Stryker Corporation, Vascular Solutions, Inc., Boston Scientific Corporation, Medtronic plc, Teleflex Incorporated, Penumbra Inc., The Spectranetics Corporation and AngioDynamics, Inc., are also provided in this report.
Key Benefits
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS/TOP PLAYER POSITIONING, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
CHAPTER 4 CEREBRAL THROMBECTOMY SYSTEMS MARKET, BY PRODUCT TYPE
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. SUCTION DEVICES
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. CATHETERS WITH BALLOONS
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.4. SNARES
4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
4.5. ENVELOPING COIL
4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast
4.6. RHEOLYTIC DEVICES
4.6.1. Key market trends
4.6.2. Growth factors and opportunities
4.6.3. Market size and forecast
4.7. LASER-BASED DEVICES
4.7.1. Key market trends
4.7.2. Growth factors and opportunities
4.7.3. Market size and forecast
CHAPTER 5 CEREBRAL THROMBECTOMY SYSTEMS MARKET, BY UTILITY
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. REUSABLE DEVICES
5.2.1. Key market trends
5.3. DISPOSABLE DEVICES
5.3.1. Key market trends
CHAPTER 6 CEREBRAL THROMBECTOMY SYSTEMSMARKET, BY REGION
6.1. OVERVIEW
6.2. NORTH AMERICA
6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.2.3.1. U.S. market size and forecast
6.2.3.2. Canada market size and forecast
6.2.3.3. Mexico market size and forecast
6.2.4. North America Cerebral Thrombectomy Systems Market by Product Type
6.2.5. North America Cerebral Thrombectomy Systems Market by Utility
6.3. EUROPE
6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.3.3.1. Germany market size and forecast
6.3.3.2. France market size and forecast
6.3.3.3. UK market size and forecast
6.3.3.4. Spain market size and forecast
6.3.3.5. Rest of Europe market size and forecast
6.3.4. Europe Cerebral Thrombectomy Systems Market by Product Type
6.3.5. Europe Cerebral Thrombectomy Systems Market by Utility
6.4. ASIA-PACIFIC
6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.4.3.1. Japan market size and forecast
6.4.3.2. China market size and forecast
6.4.3.3. Australia market size and forecast
6.4.3.4. India market size and forecast
6.4.3.5. Rest of Asia-Pacific market size and forecast
6.4.4. Asia-Pacific Cerebral Thrombectomy Systems Market by Product Type
6.4.5. Asia-Pacific Cerebral Thrombectomy Systems Market by Utility
6.5. LAMEA
6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
6.5.3.1. Brazil market size and forecast
6.5.3.2. Turkey market size and forecast
6.5.3.3. Saudi Arabia market size and forecast
6.5.3.4. South Africa market size and forecast
6.5.3.5. Rest of LAMEA market size and forecast
6.5.4. LAMEA Cerebral Thrombectomy Systems Market by Product Type
6.5.5. LAMEA Cerebral Thrombectomy Systems Market by Utility
CHAPTER 7 COMPANY PROFILES
7.1. TERUMO CORPORATION
7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments
7.2. JOHNSON AND JOHNSON, INC.
7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments
7.3. STRYKER CORPORATION
7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments
7.4. VASCULAR SOLUTIONS, INC.
7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments
7.5. BOSTON SCIENTIFIC CORPORATION
7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments
7.6. MEDTRONIC PLC
7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments
7.7. TELEFLEX INCORPORATED
7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments
7.8. PENUMBRA INC.
7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments
7.9. THE SPECTRANETICS CORPORATION
7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments
7.10. ANGIODYNAMICS, INC.
7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
10%
Discount
10%
Discount
10%
Discount
10%
Discount
Enterprise
License/PDF
10%
Discount
Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
